---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-002405"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T17:09:30.114000+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mednax reports Q3 GAAP EPS $0.37 from continuing ops, revenue $493M, adjusted EPS $0.46

## Summary
- Net revenue $492.9M, up 7% YoY; same-unit revenue +5.9%, driven by 6.5% volume increase.
- GAAP EPS $0.37 vs loss $0.03 prior year; Adjusted EPS $0.46 vs $0.37.
- Adjusted EBITDA $73.4M vs $72.8M; no CARES Act funds in Q3 2021 vs $14.2M in Q3 2020.
- Used $20M to invest in Brave Care; redeemed $750M 5.25% notes in Jan; cut revolver to $600M from $1.2B.
- Cash at Sep 30: $358M; net debt $642M; no debt on revolver.

## SEC filing metadata
- accession: 0000950170-21-002405
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/0000950170-21-002405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017021002405/md-20211028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-002405
- JSON: https://secwatch.observer/filing/0000950170-21-002405.json
- Plain text: https://secwatch.observer/filing/0000950170-21-002405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.